CN1105592A - Cihanglingdan pill - Google Patents
Cihanglingdan pill Download PDFInfo
- Publication number
- CN1105592A CN1105592A CN 94118245 CN94118245A CN1105592A CN 1105592 A CN1105592 A CN 1105592A CN 94118245 CN94118245 CN 94118245 CN 94118245 A CN94118245 A CN 94118245A CN 1105592 A CN1105592 A CN 1105592A
- Authority
- CN
- China
- Prior art keywords
- ganoderma
- medicine
- diabetes
- spore powder
- stevioside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a medicine for curing diabetes -Cihang Lingdan. It is made up by using sporopollen of lucid ganoderma as main ingredient and adding Panaxoxide, lucid ganoderma polysaccharide, gliclazidum (daimicron), cooked peanut kernel powder and stevioside.
Description
The present invention relates to a kind of medicine for the treatment of diabetes, it is to be the Chinese patent medicine that Main Ingredients and Appearance is made through certain processing technique with the Chinese herbal medicine.
Diabetes are commonly encountered diseases, frequently-occurring diseases of serious harm human health, and at present world's diabetics surpasses 100,000,000 people, and China is near 20,000,000, and the trend that increases is year by year arranged.Diabetes be a kind of be the incretion metabolism disease of main performance with the carbohydrate metabolism disturbance, can cause many serious and issue licence and various infection simultaneously.Case fatality rate is only second to malignant tumor and cardiovascular diseases, is the third-largest disease that jeopardizes the human life.The common drug of treatment diabetes comprises hypoglycemic drugs such as insulin, sulfonylurea, biguanides at present.Insulin with producing antibody, easily produces toleration for a long time; The biguanides curative effect is low, for a long time with producing hyperlactacidemia; And the sulfonylurea medicine, for a long time with infringement liver, kidney and hemocyte; With the sulphonamides cross allergy, the later stage produces secondary failure.The conventional Chinese medicine of treatment diabetes has diabetes pill, insoral etc., but this class medicine is the certain effect of performance when taking, in case stop using, the state of an illness was still as in the past.Therefore at present the medicine that aspect treating diabetes, lacks determined curative effect, consolidation and have no side effect.
Ganoderma has long history, pharmaceutical research to show that Ganoderma has effects such as antitumor, protecting liver and detoxication, blood fat reducing, blood sugar lowering, expelling phlegm for arresting cough, blood pressure lowering heart tonifying, anti-inflammatory and antalgic, adjusting central nervous system function as QI invigorating and body resistance strengthening, the use of strengthening by means of tonics class Chinese herbal medicine.However, the independent use of Ganoderma also is difficult to reach the effect of good curing diabetes.Ganoderma spore powder is the flour that Ganoderma discharges when ripe, is the elite crystallization of Ganoderma.Wind and weather makes natural wild Ganoderma can't accumulate spore powder, our ancestors just knew before several thousand and utilize Ganoderma to cure the disease, but the always unmanned release phenomenon of finding Ganoderma spore powder, the also data of books records this respect never, it is empty therefore gathering and utilizing Ganoderma spore powder always.The inventor was through more than 20 years concentrating on studies and testing, successfully realized the Ganoderma artificial culture, and through test of many times, invented and utilized the plastic sheeting bullet to put the technology of collecting spore powder, on this basis, through a large amount of clinical uses, found the peculiar drug action of Ganoderma spore treated powder diabetes, and be developed into the medicine of treatment diabetes.
The Remedies for diabetes that the object of the invention is to provide a kind of and has no side effect, therapeutic effect is good.
The composition of medicine of the present invention is by weight percentage:
Ganoderma 2-9%
Radix Ginseng 2-4%
The spore powder 85-95% of Ganoderma
Stevioside 1-2%
The Ganoderma of above-mentioned component can be the ganoderan (commercially available) that extracts from Ganoderma, and Radix Ginseng can be ginsenoside (commercially available), and can add a spot of antidiabetic drug and reach U.S. bran, also can add a spot of ripe Semen arachidis hypogaeae rice flour.
Therefore the component of medicine of the present invention can also be by weight percentage:
Ganoderma spore powder 85-94%
Ganoderan 0.4-0.6%
Ginsenoside 1-3%
Stevioside 0.5-1%
Reach U.S. bran 0.2-0.7%
Ripe Semen arachidis hypogaeae rice flour 3-6%
The optimum weight proportioning of above-mentioned component is as follows:
Ganoderma spore powder 90%
Ganoderan 0.5%
The ginsenoside 2%
Stevioside 1%
Reach U.S. bran 0.5%
Ripe Semen arachidis hypogaeae rice flour 6%
Medicine of the present invention can be made peroral dosage forms commonly used such as capsule, electuary, tablet.
Above-mentioned Ganoderma is red ganoderma preferably.The preparation method of described Ganoderma spore powder is, adopt the method production of hybrid seeds (referring to Chinese patent publication number CN87104254) of " fire combines with vapor phase ", use raw materials such as wood sawdust (broad leaf tree that does not contain oils and fats and fragrant fragrance), wheat bran, sugar, at place cultivating ganoderma away from the city, and adopt the plastic sheeting bullet to put collection method and collect the spore powder that Ganoderma discharges, concrete collection method is to surround Ganoderma with thin film, and the spore powder that the Ganoderma bullet is put is collected on the thin film.Because mycelia is not used agriculture chemical in growth course.Therefore Ganoderma that cultivates and spore powder are identified nontoxic, nuisanceless through State Bureau of Environmental Protection.
Medicine of the present invention uses proof through clinical patient, and diabetes are had excellent curative, has no side effect.Has Remedies for diabetes special efficacy can't be obtained at present commonly used.The clinical observation effective percentage is more than 90%.
Embodiment:
Get spore powder 90 grams of Ganoderma, ganoderan (commercially available) 0.5 gram, ginsenoside (commercially available) 2 grams, stevioside 1 gram reaches U.S. sugar 0.5 gram, ripe Semen arachidis hypogaeae rice flour (crossing 100 mesh sieves) 6 grams.Above-mentioned component is fully mixed, encapsulated, make 100.
Claims (3)
1, a kind of medicine for the treatment of diabetes is characterized in that it contains the component of following weight percentage ratio:
Ganoderma 2-9%
Radix Ginseng 2-4%
The spore powder 85-95% of Ganoderma
Stevioside 1-2%
2, a kind of medicine for the treatment of diabetes is characterized in that it contains the component of following weight percentage ratio:
Ganoderma spore powder 85-94%
Ganoderan 0.4-0.6%
Ginsenoside 1-3%
Stevioside 0.5-1%
Reach U.S. bran 0.2-0.7%
Ripe Semen arachidis hypogaeae rice flour 3-6%
3,, it is characterized in that it contains the component of following weight percentage ratio according to the medicine of claim 2:
Ganoderma spore powder 90%
Ganoderan 0.5%
The ginsenoside 2%
Stevioside 1%
Reach U.S. bran 0.5%
Ripe Semen arachidis hypogaeae rice flour 6%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94118245 CN1105592A (en) | 1994-11-16 | 1994-11-16 | Cihanglingdan pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94118245 CN1105592A (en) | 1994-11-16 | 1994-11-16 | Cihanglingdan pill |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1105592A true CN1105592A (en) | 1995-07-26 |
Family
ID=5038705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94118245 Pending CN1105592A (en) | 1994-11-16 | 1994-11-16 | Cihanglingdan pill |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1105592A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391072B (en) * | 2007-09-21 | 2010-12-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic diarrhea |
-
1994
- 1994-11-16 CN CN 94118245 patent/CN1105592A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391072B (en) * | 2007-09-21 | 2010-12-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic diarrhea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1762236B (en) | Health-caring product capable of increasing human immunity and its preparation method | |
| CN103860580B (en) | It is a kind of have strengthen the body resistance to consolidate the constitution, the composite fungi amylose preparation of strengthening the spleen and stomach, strengthen immunity function | |
| CN101507757B (en) | Compound Chinese medicine for treating diabetes | |
| KR20060121576A (en) | A crude exopolysaccharides produced from phellinus baumii mycellium having hypoglycemic activity and preparation method thereof | |
| CN1103305A (en) | Diabetes powder and its preparing method | |
| CN1150018C (en) | Medicine for treating tachy-arrhythmia | |
| CN1136874C (en) | Composite medicine for treating hyperlipemia | |
| CN105381211A (en) | Ganoderma lucidum mycelium composition and preparation method and application thereof | |
| CN104606487A (en) | Fermented traditional Chinese medicine preparation as well as preparation method and application thereof | |
| CN1105594A (en) | Jiangailing pill | |
| CN1105592A (en) | Cihanglingdan pill | |
| CN105687480A (en) | Immunoregulatory traditional Chinese medicine composition and preparation | |
| CN106309736B (en) | Anti-fatigue Chinese medicinal composition and its preparation method and application | |
| CN1706444A (en) | Prepn for treating fatty liver and alcoholic liver and its prepn process | |
| CN1233364C (en) | Chinese medicine for treating digestive ulcerating sore and its preparation method | |
| CN1452972A (en) | Plant extractive composition containing ginkgetin and its use | |
| Rissa et al. | Comparison of The Effectiveness of Ethanol Extract and Infusion of Leaf of Binahong (Anredera Cordifolia Steen) as Antidiabetes In Male Rats Alloksan Induced | |
| CN1557378A (en) | Medicine for treating diabetes | |
| CN108456613A (en) | A kind of health care's wine and its preparation method | |
| CN1575803A (en) | Application method of Aloe vera L. extract in preventing and curing diabetes | |
| CN1463743A (en) | Capsule possessing antisenescent and spot dispelling effect and method for making the same | |
| CN1686322A (en) | Blood fat reducing granules containing seed of pepper weed or flixweed tansymustard | |
| CN106074854A (en) | A kind of Chinese medicine health-care oral liquid and preparation method thereof | |
| CN1105593A (en) | Hemostatic pill | |
| CN1583068A (en) | Health care food for regulating blood sugar and immunologic function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Pan Zihang Document name: payment instructions |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Pan Zihang Document name: Deemed as a notice of withdrawal |
|
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |